{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:31:22Z","timestamp":1789605082299,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41401-025-01705-5","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:40:04Z","timestamp":1768556404000},"page":"1219-1232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PPAR\u03b2\/\u03b4 contributes to the antidiabetic effect and the increase in GDF15 caused by metformin"],"prefix":"10.1038","volume":"47","author":[{"given":"Javier","family":"Jurado-Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Peyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Balsinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela M.","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Palomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"V\u00e1zquez-Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"1705_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","volume":"29","author":"S Patel","year":"2019","unstructured":"Patel S, Alvarez-Guaita A, Melvin A, Rimmington D, Dattilo A, Miedzybrodzka EL, et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 2019;29:707\u201318.e708.","journal-title":"Cell Metab"},{"key":"1705_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","volume":"83","author":"SN Breit","year":"2021","unstructured":"Breit SN, Brown DA, Tsai VW. The GDF15\u2013GFRAL pathway in health and metabolic disease: friend or foe?. Annu Rev Physiol. 2021;83:127\u201351.","journal-title":"Annu Rev Physiol"},{"key":"1705_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/ijo.2017.258","volume":"42","author":"VW Tsai","year":"2018","unstructured":"Tsai VW, Zhang HP, Manandhar R, Lee-Ng KKM, Lebhar H, Marquis CP, et al. Treatment with the TGF-\u03b2 superfamily cytokine MIC-1\/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity. Int J Obes. 2018;42:561\u201371.","journal-title":"Int J Obes"},{"key":"1705_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/endrev\/bnaa007","volume":"41","author":"SM Lockhart","year":"2020","unstructured":"Lockhart SM, Saudek V, O\u2019Rahilly S. GDF15: a hormone conveying somatic distress to the brain. Endocr Rev. 2020;41:4.","journal-title":"Endocr Rev"},{"key":"1705_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai VWW, Husaini Y, Sainsbury A, Brown DA, Breit SN. The MIC-1\/GDF15\u2013GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell Metab. 2018;28:353\u201368.","journal-title":"Cell Metab"},{"key":"1705_CR6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.tem.2022.08.004","volume":"33","author":"D Aguilar-Recarte","year":"2022","unstructured":"Aguilar-Recarte D, Barroso E, Palomer X, Wahli W, Vazquez-Carrera M. Knocking on GDF15\u2019s door for the treatment of type 2 diabetes mellitus. Trends Endocrinol Metab. 2022;33:741\u201354.","journal-title":"Trends Endocrinol Metab"},{"key":"1705_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111947","volume":"42","author":"JY Kim-Muller","year":"2023","unstructured":"Kim-Muller JY, Song L, LaCarubba PB, Pashos E, Li X, Rinaldi A, et al. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia. Cell Rep. 2023;42:111947.","journal-title":"Cell Rep"},{"key":"1705_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep12870","volume":"5","author":"KH Tsui","year":"2015","unstructured":"Tsui KH, Hsu SY, Chung LC, Lin YH, Feng TH, Lee TY, et al. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells. Sci Rep. 2015;5:12870.","journal-title":"Sci Rep"},{"key":"1705_CR9","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1074\/jbc.M305295200","volume":"279","author":"SJ Baek","year":"2004","unstructured":"Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE. Expression of NAG-1, a transforming growth factor-\u03b2 superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem. 2004;279:6883\u201392.","journal-title":"J Biol Chem"},{"key":"1705_CR10","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000954R","volume":"35","author":"LK Townsend","year":"2021","unstructured":"Townsend LK, Weber AJ, Day EA, Shamshoum H, Shaw SJ, Perry CGR, et al. AMPK mediates energetic stress-induced liver GDF15. FASEB J. 2021;35:e21218.","journal-title":"FASEB J"},{"key":"1705_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109501","volume":"36","author":"D Aguilar-Recarte","year":"2021","unstructured":"Aguilar-Recarte D, Barroso E, Guma A, Pizarro-Delgado J, Pena L, Ruart M, et al. GDF15 mediates the metabolic effects of PPAR\u03b2\/\u03b4 by activating AMPK. Cell Rep. 2021;36:109501.","journal-title":"Cell Rep"},{"key":"1705_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jhep.2019.12.004","volume":"72","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Xu X, Tian W, Jiang R, Lu Y, Sun Q, et al. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation. J Hepatol. 2020;72:976\u201389.","journal-title":"J Hepatol"},{"key":"1705_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pharmthera.2019.02.008","volume":"198","author":"SJ Baek","year":"2019","unstructured":"Baek SJ, Eling T. Growth differentiation factor 15 (GDF15): a survival protein with therapeutic potential in metabolic diseases. Pharmacol Ther. 2019;198:46\u201358.","journal-title":"Pharmacol Ther"},{"key":"1705_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/MCB.00249-18","volume":"38","author":"JJ Li","year":"2018","unstructured":"Li JJ, Liu J, Lupino K, Liu X, Zhang L, Pei L. Growth differentiation factor 15 maturation requires proteolytic cleavage by PCSK3, -5, and -6. Mol Cell Biol. 2018;38:21.","journal-title":"Mol Cell Biol"},{"key":"1705_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017;23:1215\u20139.","journal-title":"Nat Med"},{"key":"1705_CR16","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican SE, Lin-Schmidt X, Chin CN, Chavez JA, Furman JL, Armstrong AA, et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med. 2017;23:1150\u20137.","journal-title":"Nat Med"},{"key":"1705_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017;550:255\u20139.","journal-title":"Nature"},{"key":"1705_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Chang CC, Sun Z, Madsen D, Zhu H, Padkjaer SB, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23:1158\u201366.","journal-title":"Nat Med"},{"key":"1705_CR19","doi-asserted-by":"publisher","first-page":"F1249","DOI":"10.1152\/ajprenal.00387.2013","volume":"305","author":"M Mazagova","year":"2013","unstructured":"Mazagova M, Buikema H, van Buiten A, Duin M, Goris M, Sandovici M, et al. Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes. Am J Physiol Ren Physiol. 2013;305:F1249\u201356.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1705_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2337\/dc16-1682","volume":"40","author":"HC Gerstein","year":"2017","unstructured":"Gerstein HC, Pare G, Hess S, Ford RJ, Sjaarda J, Raman K, et al. Growth differentiation factor 15 as a novel biomarker for metformin. Diabetes Care. 2017;40:280\u20133.","journal-title":"Diabetes Care"},{"key":"1705_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll AP, Chen M, Taskar P, Rimmington D, Patel S, Tadross JA, et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature. 2020;578:444\u20138.","journal-title":"Nature"},{"key":"1705_CR22","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s42255-019-0146-4","volume":"1","author":"EA Day","year":"2019","unstructured":"Day EA, Ford RJ, Smith BK, Mohammadi-Shemirani P, Morrow MR, Gutgesell RM, et al. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat Metab. 2019;1:1202\u20138.","journal-title":"Nat Metab"},{"key":"1705_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111258","volume":"40","author":"AB Klein","year":"2022","unstructured":"Klein AB, Nicolaisen TS, Johann K, Fritzen AM, Mathiesen CV, Gil C, et al. The GDF15\u2013GFRAL pathway is dispensable for the effects of metformin on energy balance. Cell Rep. 2022;40:111258.","journal-title":"Cell Rep"},{"key":"1705_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106578","volume":"187","author":"D Aguilar-Recarte","year":"2023","unstructured":"Aguilar-Recarte D, Barroso E, Zhang M, Rada P, Pizarro-Delgado J, Pena L, et al. A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects. Pharmacol Res. 2023;187:106578.","journal-title":"Pharmacol Res"},{"key":"1705_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51866-2","volume":"14","author":"JWR Kincaid","year":"2024","unstructured":"Kincaid JWR, Rimmington D, Tadross JA, Cimino I, Zvetkova I, Kaser A, et al. The gastrointestinal tract is a major source of the acute metformin-stimulated rise in GDF15. Sci Rep. 2024;14:1899.","journal-title":"Sci Rep"},{"key":"1705_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cmet.2023.03.014","volume":"35","author":"SY Zhang","year":"2023","unstructured":"Zhang SY, Bruce K, Danaei Z, Li RJW, Barros DR, Kuah R, et al. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight. Cell Metab. 2023;35:875\u201386.e875.","journal-title":"Cell Metab"},{"key":"1705_CR27","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1073\/pnas.0511253103","volume":"103","author":"CH Lee","year":"2006","unstructured":"Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, et al. PPAR\u03b4 regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA. 2006;103:3444\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1705_CR28","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem MA, O\u2019Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 2002;13:630\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"1705_CR29","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1016\/j.bbamcr.2015.09.020","volume":"1853","author":"B Santamaria","year":"2015","unstructured":"Santamaria B, Marquez E, Lay A, Carew RM, Gonzalez-Rodriguez A, Welsh GI, et al. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Biochim Biophys Acta. 2015;1853:3224\u201333.","journal-title":"Biochim Biophys Acta"},{"key":"1705_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155772","volume":"152","author":"J Jurado-Aguilar","year":"2024","unstructured":"Jurado-Aguilar J, Barroso E, Bernard M, Zhang M, Peyman M, Rada P, et al. GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-\u03b21\/SMAD3 pathway. Metabolism. 2024;152:155772.","journal-title":"Metabolism"},{"key":"1705_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.201607110","volume":"216","author":"HK Chung","year":"2017","unstructured":"Chung HK, Ryu D, Kim KS, Chang JY, Kim YK, Yi HS, et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J Cell Biol. 2017;216:149\u201365.","journal-title":"J Cell Biol"},{"key":"1705_CR32","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2017.04.029","volume":"25","author":"JH Koh","year":"2017","unstructured":"Koh JH, Hancock CR, Terada S, Higashida K, Holloszy JO, Han DH. PPAR\u03b2 is essential for maintaining normal levels of PGC-1\u03b1 and mitochondria and for the increase in muscle mitochondria induced by exercise. Cell Metab. 2017;25:1176\u201385 e1175.","journal-title":"Cell Metab"},{"key":"1705_CR33","doi-asserted-by":"publisher","first-page":"36741","DOI":"10.1074\/jbc.M003848200","volume":"275","author":"A Cameron","year":"2000","unstructured":"Cameron A, Appel J, Houghten RA, Lindberg I. Polyarginines are potent furin inhibitors. J Biol Chem. 2000;275:36741\u20139.","journal-title":"J Biol Chem"},{"key":"1705_CR34","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/ijo.2014.27","volume":"38","author":"K Chrysovergis","year":"2014","unstructured":"Chrysovergis K, Wang X, Kosak J, Lee SH, Kim JS, Foley JF, et al. NAG-1\/GDF15 prevents obesity by increasing thermogenesis, lipolysis, and oxidative metabolism. Int J Obes. 2014;38:1555\u201364.","journal-title":"Int J Obes"},{"key":"1705_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.physbeh.2013.01.011","volume":"110\u201311","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Zhang XH, Park EY, Shin KH, Choi SH, Chun BG, et al. Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice. Physiol Behav. 2013;110\u201311:213\u201320.","journal-title":"Physiol Behav"},{"key":"1705_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1042\/CS20100061","volume":"119","author":"V Souza-Mello","year":"2010","unstructured":"Souza-Mello V, Gregorio BM, Cardoso-de-Lemos FS, de Carvalho L, Aguila MB, Mandarim-de-Lacerda CA. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodeling in C57BL\/6 mice fed on a very high-fat diet. Clin Sci. 2010;119:239\u201350.","journal-title":"Clin Sci"},{"key":"1705_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41574-022-00764-6","volume":"19","author":"JWR Kincaid","year":"2023","unstructured":"Kincaid JWR, Coll AP. Metformin and GDF15: where are we now?. Nat Rev Endocrinol. 2023;19:6\u20137.","journal-title":"Nat Rev Endocrinol"},{"key":"1705_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948804","volume":"21","author":"M Ost","year":"2020","unstructured":"Ost M, Igual Gil C, Coleman V, Keipert S, Efstathiou S, Vidic V, et al. Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress. EMBO Rep. 2020;21:e48804.","journal-title":"EMBO Rep"},{"key":"1705_CR39","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","volume":"289","author":"J Cao","year":"2014","unstructured":"Cao J, Meng S, Chang E, Beckwith-Fickas K, Xiong L, Cole RN, et al. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). J Biol Chem. 2014;289:20435\u201346.","journal-title":"J Biol Chem"},{"key":"1705_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022;603:159\u201365.","journal-title":"Nature"},{"key":"1705_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejphar.2009.08.024","volume":"620","author":"RS Meng","year":"2009","unstructured":"Meng RS, Pei ZH, Yin R, Zhang CX, Chen BL, Zhang Y, et al. AMP-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-\u03b1 signaling pathway. Eur J Pharmacol. 2009;620:63\u201370.","journal-title":"Eur J Pharm"},{"key":"1705_CR42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1152\/japplphysiol.00698.2021","volume":"132","author":"LK Townsend","year":"2022","unstructured":"Townsend LK, Medak K, Weber AJ, Dibe H, Shamshoum H, Wright DC. CHOP is dispensable for exercise-induced increases in GDF15. J Appl Physiol. 2022;132:413\u201322.","journal-title":"J Appl Physiol"},{"key":"1705_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81349-7","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang M, Darwish T, Larraufie P, Rimmington D, Cimino I, Goldspink DA, et al. Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF15 release from intestinal cells. Sci Rep. 2021;11:2529.","journal-title":"Sci Rep"},{"key":"1705_CR44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211933120","volume":"120","author":"N Tobar","year":"2023","unstructured":"Tobar N, Rocha GZ, Santos A, Guadagnini D, Assalin HB, Camargo JA, et al. Metformin acts in the gut and induces gut\u2013liver crosstalk. Proc Natl Acad Sci USA. 2023;120:e2211933120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1705_CR45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1476-5381.1994.tb13128.x","volume":"112","author":"CJ Bailey","year":"1994","unstructured":"Bailey CJ, Mynett KJ, Page T. Importance of the intestine as a site of metformin-stimulated glucose utilization. Br J Pharmacol. 1994;112:671\u20135.","journal-title":"Br J Pharm"},{"key":"1705_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1042\/bj2620881","volume":"262","author":"L Penicaud","year":"1989","unstructured":"Penicaud L, Hitier Y, Ferre P, Girard J. Hypoglycaemic effect of metformin in genetically obese (fa\/fa) rats results from an increased utilization of blood glucose by intestine. Biochem J. 1989;262:881\u20135.","journal-title":"Biochem J"},{"key":"1705_CR47","doi-asserted-by":"publisher","unstructured":"Wang HH, Lin SH, Hung SY, Chiou YY, Hsu WC, Chang CM, et al. Renal protective effect of metformin in type 2 diabetes patients. J Clin Endocrinol Metab. 2024. https:\/\/doi.org\/10.1210\/clinem\/dgae123.","DOI":"10.1210\/clinem\/dgae123"},{"key":"1705_CR48","doi-asserted-by":"publisher","first-page":"F1229","DOI":"10.1152\/ajprenal.00539.2019","volume":"318","author":"CM Borges","year":"2020","unstructured":"Borges CM, Fujihara CK, Malheiros D, de Avila VF, Formigari GP, Lopes de Faria JB. Metformin arrests the progression of established kidney disease in the subtotal nephrectomy model of chronic kidney disease. Am J Physiol Ren Physiol. 2020;318:F1229\u201336.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1705_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.12669\/pjms.35.1.100","volume":"35","author":"M Rashid","year":"2019","unstructured":"Rashid M, Shahzad M, Mahmood S, Khan K. Variability in the therapeutic response of metformin treatment in patients with type 2 diabetes mellitus. Pak J Med Sci. 2019;35:71\u20136.","journal-title":"Pak J Med Sci"},{"key":"1705_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S2213-8587(14)70050-6","volume":"2","author":"K Zhou","year":"2014","unstructured":"Zhou K, Donnelly L, Yang J, Li M, Deshmukh H, Van Zuydam N, et al. Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis. Lancet Diabetes Endocrinol. 2014;2:481\u20137.","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01705-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:04:45Z","timestamp":1777025085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01705-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01705-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}